Original Research

The Efficacy and Safety of PD-1 Inhibitors Combined with Nab-Paclitaxel Plus Gemcitabine versus Nab-Paclitaxel Plus Gemcitabine in the First-Line Treatment of Advanced Pancreatic Cancer: A Retrospective Monocentric Study

Zhang F, Wang Y, Yang F, Zhang Y, Jiang M, Zhang X

Cancer Management and Research 2022, 14:535-546

Published Date: 9 February 2022